<DOC>
	<DOC>NCT00816712</DOC>
	<brief_summary>This is a study to evaluate the use of fractional synthetic rate as an early biomarker of muscle anabolism (muscle build-up).</brief_summary>
	<brief_title>A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)</brief_title>
	<detailed_description />
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Subject is weight stable over the past 3 months Patient agrees to refrain from consumption of alcohol from 48 hours prior to entering the study Subject agrees to follow the study restriction of no caffeine while on study Patient agrees to following the meatfree controlled protein weightmaintaining diet Patient is willing to avoid strenuous physical activity Patient has been a nonsmoker for at least 6 months prior to study start Subject is currently a regular user of any illicit drugs Subject has taken androgenic steroids in the previous 12 months Subject has participated in sports events, resistance exercise training or heavy exercise in the previous month Subject has prostate cancer Subject has a history of cancer except basalcell tumors Subject has been diagnosed with HIV Subject has been diagnosed with Hepatitis B or C Subject uses certain antiinflammatory drugs such as ibuprofen, arcoxia or celecoxib Subject uses a blood anticoagulant, such as Coumadin (Warfarin) or high doses of aspirin Subject is currently taking over the counter supplements such as "muscle builders" or "fat burners" Subject has an allergy or hypersensitivity to intramuscular testosterone Subject has sciatica Subject has donated blood products or has had phlebotomy within 2 months of signing informed consent Subject has undergone a surgical procedure within 1 month of signing informed consent Subject is currently participating or has participated in a study with an investigational drug or device</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Males with low-normal serum total testosterone levels.</keyword>
</DOC>